CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282 | +5.2% | 8,069 | +0.2% | 0.01% | 0.0% |
| Q2 2023 | $268 | -5.6% | 8,050 | -0.5% | 0.01% | -14.3% |
| Q1 2023 | $284 | -23.2% | 8,089 | +0.2% | 0.01% | -22.2% |
| Q4 2022 | $370 | -99.9% | 8,070 | -1.5% | 0.01% | -18.2% |
| Q3 2022 | $397,000 | +31.5% | 8,190 | +6.4% | 0.01% | +37.5% |
| Q2 2022 | $302,000 | +4.1% | 7,700 | -2.2% | 0.01% | +33.3% |
| Q1 2022 | $290,000 | -19.0% | 7,870 | +0.3% | 0.01% | -25.0% |
| Q4 2021 | $358,000 | -37.6% | 7,850 | -51.1% | 0.01% | -38.5% |
| Q3 2021 | $574,000 | +80.5% | 16,050 | -0.2% | 0.01% | +85.7% |
| Q2 2021 | $318,000 | -14.3% | 16,080 | +0.8% | 0.01% | -22.2% |
| Q1 2021 | $371,000 | +16.3% | 15,950 | +4.0% | 0.01% | +12.5% |
| Q4 2020 | $319,000 | +2.6% | 15,340 | -28.5% | 0.01% | 0.0% |
| Q3 2017 | $311,000 | 0.0% | 21,460 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $311,000 | – | 21,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |